Watch ACTU. Know when insiders buy.
One email the day a filing lands. Free.
ACTU
ACTUATE THERAPEUTICS, INC.
1.48
+0.11 +8.03%
USD · close Sep 4
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
0
FLAG · shorts 0
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $35.5MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$20.5MNET CASH —52W 0.97 – 8.51SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$4.9M | −$4.9M | — | -0.20 | −$4.4M | — | — | Aug 14 |
| Q1 2026 · Mar 31 | — | — | — | −$5.7M | −$5.6M | — | -0.24 | −$5M | — | — | Aug 14 |
| Q4 2025 · Dec 31derived | — | — | — | −$4.7M | −$4.6M | — | -0.18 | −$3.7M | — | — | Mar 26 |
| Q3 2025 · Sep 30 | — | — | — | −$5.5M | −$5.4M | — | -0.25 | −$6.7M | — | — | Nov 13 |
| Q2 2025 · Jun 30 | — | — | — | −$6M | −$5.9M | — | -0.30 | −$4.2M | — | — | Aug 14 |
| Q1 2025 · Mar 31 | — | — | — | −$6.4M | −$6.3M | — | -0.32 | −$4.6M | — | — | Aug 14 |
| Q4 2024 · Dec 31derived | — | — | — | −$6.6M | −$6.4M | — | 1.22 | −$4.8M | — | — | Mar 26 |
| Q3 2024 · Sep 30 | — | — | — | −$5.4M | −$6M | — | -0.55 | −$9.1M | — | — | Nov 13 |
| Q2 2024 · Jun 30 | — | — | — | −$5.4M | −$6.6M | — | -4.20 | −$2.7M | — | — | Nov 13 |
| Q1 2024 · Mar 31 | — | — | — | −$7.8M | −$8.3M | — | -5.40 | −$5.2M | — | — | Nov 13 |
| Q4 2023 · Dec 31derived | — | — | — | −$7.6M | −$7.6M | — | -5.11 | −$5.5M | — | — | Mar 13 |
| Q3 2023 · Sep 30 | — | — | — | −$6.5M | −$6.3M | — | -4.31 | −$5.6M | — | — | Nov 13 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$22.5M | −$22.2M | — | -1.06 | −$19.2M | — | — | — | — |
| FY2024 · to Dec 31 | — | — | −$25.2M | −$27.3M | — | -3.26 | −$21.8M | — | — | — | — |
| FY2023 · to Dec 31 | — | — | −$25M | −$24.7M | — | -17.24 | −$21.6M | — | — | — | — |
Every number comes from ACTUATE THERAPEUTICS, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.